BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for September 2017
I saw my oncologist today. The news was as expected. Zytiga didn't help, and he has nothing more to offer me that I'm willing to accept. My cancer is growing...Read More
In this article from The New Yorker, Pulitzer Prize winning journalist Siddhartha Mukherjee considers a new way of looking at the cancer problem, and how we might predict which tumors...Read More